Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2009
08/20/2009WO2009073069A3 Genes and uses for plant enhancement
08/20/2009WO2009066967A3 Microrna antisense pnas, compositions comprising the same, and methods for using and evaluating the same
08/20/2009WO2009065001A3 Cardiac conduction system (ccs) progenitor cells and uses thereof
08/20/2009WO2009059078A3 Method of genetically altering and producing allergy free cats
08/20/2009WO2009043565A8 Method for identifying the interaction partner of an active agent
08/20/2009WO2009043354A3 Combination treatment for the treatment of hepatitis c virus infection
08/20/2009WO2009043353A3 Micromirs
08/20/2009WO2009038760A3 Human gm-csf antigen binding proteins
08/20/2009WO2009029342A3 B7-dc variants
08/20/2009WO2009023360A3 Bacterial packaging strains useful for generation and production of recombinant double-stranded rna nucleocapsids and uses thereof
08/20/2009WO2009023358A3 Compositions for use in identification of strains of hepatitis c virus
08/20/2009WO2009006624A3 Ubiad1 gene and hyperlipidemia
08/20/2009WO2009004484A3 Trim24 (tifla) as p53 modulator and cancer target
08/20/2009WO2007021841A9 Identification and engineering of antibodies with variant fc regions and methods of using same
08/20/2009US20090210970 Plant Genomic DNA Flanking SPT Event and Methods for Identifying SPT Event
08/20/2009US20090210969 Antiporter gene from porteresia coarctata for conferring stress tolerance
08/20/2009US20090210968 Drought Responsive Genes In Plants And Methods Of Their Use
08/20/2009US20090210967 Glutamate Receptors as Regulators of Carbon Transport, Mobilization, Distribution, Reallocation, and Partitioning in Higher Plants
08/20/2009US20090210966 rice blast susceptibility gene pi21, resistance gene pi21 and uses thereof
08/20/2009US20090210965 Sweet pepper hybrid 9942815
08/20/2009US20090210964 CUCUMBER LINE APD147-4004Mo
08/20/2009US20090210963 Cotton variety pm 2141 b2rf
08/20/2009US20090210962 Cotton variety dp 161 b2rf
08/20/2009US20090210961 Cotton variety 05v341
08/20/2009US20090210960 Celery Cultivar ADS-16
08/20/2009US20090210955 Shrna and sirna expression in a living organism under control of a codon-optimized repressor gene
08/20/2009US20090210954 Genes
08/20/2009US20090210951 Avian transgenesis using an ovalbumin nucleotide sequence
08/20/2009US20090210950 Methods for screening for agents that affect development
08/20/2009US20090209774 Expression vector comprising nucleotide sequences coding acyl-CoA:lysophospholipid-acyltransferase for enhancing production of dihmo-gama-linolenic, arachidonic, eisosapentaenoic, docosapentaenoic acid and/or docosahexaenoic acids
08/20/2009US20090209749 Plant centromere compositions
08/20/2009US20090209748 comprise at least one Locked Nucleic Acid (LNA) selected from beta-D-thio/amino-LNA or alpha-L-oxy/thio/amino-LNA; useful in antisense therapy
08/20/2009US20090209747 Method to inhibit cell growth using oligonucleotides
08/20/2009US20090209732 Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same
08/20/2009US20090209730 Method for gene transfer into target cells with retrovirus
08/20/2009US20090209729 Recombinant chemokine-antigen vaccine
08/20/2009US20090209630 Vectors carrying coding sequences for angiogenic agents such as Del-1or VEGF formulated with poloxamers to improve bioavailability; avoids problems with toxicity inherent to existing delivery technologies; treating ischemia in a muscle, kidney or brain tissue
08/20/2009US20090209629 Nucleic Acid Functionalized Nanoparticles for Therapeutic Applications
08/20/2009US20090209628 MULTIPLE RNAi EXPRESSION CASSETTES FOR SIMULTANEOUS DELIVERY OF RNAi AGENTS RELATED TO HETEROZYGOTIC EXPRESSION PATTERNS
08/20/2009US20090209627 RNAi-MEDIATED INHIBITION OF CONNEXIN 43 FOR TREATMENT OF IOP-RELATED CONDITIONS
08/20/2009US20090209621 Compositions and methods for decreasing microrna expression for the treatment of neoplasia
08/20/2009US20090209620 Direct Reversal Of The Suppressive Function Of CD4+Regulatory T Cells Via Toll-Like Receptor 8 Signaling
08/20/2009US20090209618 Pyruvate dehydrogenase kinases as therapeutic targets for cancer and ischemic diseases
08/20/2009US20090209478 Compositions and methods for inhibiting expression of the hamp gene
08/20/2009US20090209472 Amide and peptide derivatives of dialkylenetriamines and their use as transfection agents
08/20/2009US20090209470 T24 antigen for immunodiagnosis of taenia solium cysticercosis
08/20/2009US20090209458 Cell-penetrating socs polypeptides that inhibit cytokine-induced signaling
08/20/2009US20090209453 Glycoprotein Hormone Analogs
08/20/2009US20090209437 Temperature regulated promoters from schizosaccharomyces pombe for expression of proteins
08/20/2009US20090209435 Methods of screening for TRPM4b modulators
08/20/2009US20090209427 Microbial glyphosate resistant epsps
08/20/2009US20090209039 Method and apparatus for microfluidic injection
08/20/2009US20090209038 Cell-Mediated Directed Evolution
08/20/2009US20090209037 Viral core protein-cationic lipid-nucleic acid-delivery complexes
08/20/2009US20090209036 Method for Accelerating Somatic Mutations and use Thereof in Proteomics
08/20/2009US20090209034 Tumour rejection antigens
08/20/2009US20090209033 Immortalized hepatocyte cell line secreting modified insulin with glucose sensitivity
08/20/2009US20090209032 Feeding buffers, systems, and methods for in vitro synthesis of biomolecules
08/20/2009US20090209024 Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
08/20/2009US20090209021 Variant Form of Urate Oxidase and Use Thereof
08/20/2009US20090209016 Engineering Fungi for the Utilisation of L-Arabinose
08/20/2009US20090209012 Method for producing l-amino acids
08/20/2009US20090209008 Thermus thermophilus nucleic acid polymerases
08/20/2009US20090209007 Method of Expression Cloning in a Host Cell
08/20/2009US20090209006 Taci-immunoglobulin fusion proteins
08/20/2009US20090209005 Chimeric dna polymerase
08/20/2009US20090209004 Human il-1 beta antagonists
08/20/2009US20090209002 Compositions and methods relating to cellular targeting
08/20/2009US20090209001 2-Deoxy-D-Ribose 5-Phosphate Aldolases (DERAS) And Uses Thereof
08/20/2009US20090209000 Genetically Programmed Expression of Proteins
08/20/2009US20090208978 Panel Cell Used for Granulocyte Antibody Detection
08/20/2009US20090208974 Human Neuronal Attachment Factor-1
08/20/2009US20090208973 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders
08/20/2009US20090208972 Cytotoxic protein and utlization thereof
08/20/2009US20090208970 Probe for detection and quantification of inositol-1,4,5-trisphosphate and a method for detecting and quantifying inositol-1,4,5-trisphosphate using the same
08/20/2009US20090208969 Polynucleotides and Polypeptides Encoding Receptors
08/20/2009US20090208963 Gene Involved in V(D)J recombination and/or DNA repair
08/20/2009US20090208949 Phosphatidylinositol phosphate kinase type i gamma splice variants as biomarkers and drug targets for epithelial cancers
08/20/2009US20090208938 Use of the MCM8 Gene for the Preparation of a Pharmaceutical Composition
08/20/2009US20090208936 Identification of molecular interactions and therapeutic uses thereof
08/20/2009US20090208931 Gene Expression Level Normalization Method, Program and System
08/20/2009US20090208927 Methods of detecting sequence-specific DNA binding proteins
08/20/2009US20090208634 Soybean Cultivar 26034631
08/20/2009US20090208632 Generation of plants with altered oil content
08/20/2009US20090208564 Compositions of asymmetric interfering RNA and uses thereof
08/20/2009US20090208534 Attenuated salmonella as a delivery system for sirna-based tumor therapy
08/20/2009US20090208531 Antiviral agents and vaccines against influenza
08/20/2009US20090208530 HIV polynucleotides and polypeptides derived from Botswana MJ4
08/20/2009US20090208528 Empty capsids (vlps(-vp4)) of the infectious bursal disease virus (ibdv), obtainment process and applications
08/20/2009US20090208527 Multi plasmid system for the production of influenza virus
08/20/2009US20090208522 Neutralizing Epitope-Based Growth Enhancing Vaccine
08/20/2009US20090208518 Immunogenic peptides for the treatment of prostate and breast cancer
08/20/2009US20090208516 Promoter for introducing a gene into a lymphocyte or blood cell and application thereof
08/20/2009US20090208515 Vaccine composition
08/20/2009US20090208506 Antibodies against flagellin and uses thereof
08/20/2009US20090208504 Polypeptides involved in immune response
08/20/2009US20090208500 Method of producing antibodies with improved function
08/20/2009US20090208497 Humanized anti-cd4 antibody with immunosuppressive properties
08/20/2009US20090208496 Humanized anti-cd4 antibody with immunosuppressive properties
08/20/2009US20090208489 Antibodies That Bind OV064 and Methods of Use Therefor
1 ... 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 ... 4023